NOVT insider trading
NasdaqGS TechnologyNOVANTA INC: insider trade history from SEC Form 4 filings.
About NOVANTA INC
Novanta Inc., together with its subsidiaries, provides precision medicine, precision manufacturing, medical solutions, robotics and automation solutions, and advanced surgery solutions in the United States and internationally. It operates in two segments, Automation Enabling Technologies and Medical Solutions. The Precision Medicine and Manufacturing segment designs, manufactures, and markets laser beam delivery components, laser beam delivery solutions, CO2 lasers, solid state lasers, ultrafast lasers, optical and inductive encoders, precision motors, integrated stepper motors, servo drives, motion control solutions, intelligent robotic end-of-arm technology solutions, and air bearing spindles. This segment serves advanced industrial processes, advanced industrial and medical robotics, other medical and life science automation applications, and medical laser procedures, such as ophthalmology applications. The Medical Solutions segment provides a range of medical grade technologies, including medical insufflators, pumps, and related disposables; laser beam delivery solutions; video processing, streaming, and capture; machine vision technologies; radio frequency identification (RFID) technologies; barcode identification technologies; thermal chart recorders; light and color measurement technologies; touch panel displays; and advanced motion control solutions. The company sells its products through its direct sales force and distributors under the Cambridge Technology, Synrad, Laser Quantum, ARGES, WOM, NDS, Med X Change, Reach Technology, JADAK, ThingMagic, Photo Research, General Scanning, ATI Industrial Automation, Celera Motion, IMS, MicroE, Applimotion, Zettlex, Ingenia, and Westwind brands. The company was formerly known as GSI Group, Inc. and changed its name to Novanta Inc. in May 2016. Novanta Inc. was incorporated in 1968 and is headquartered in Bedford, Massachusetts.
Company website: www.novanta.com
NOVT insider activity at a glance
FilingIQ tracks 715 insider transactions for NOVT in filings since May 17, 2016. The most recent transaction is dated Sep 11, 2026.
Across the full history, 0 open-market purchases
and 274 open-market sales
were filed under transaction codes P and S respectively. Compensatory share awards
(code A) and option exercises (code M) are tracked separately and not counted here.
The average FilingIQ composite score on NOVT insider trades is 62.8/100, produced by FilingIQ's multi-factor Form 4 model. Model framework documented at methodology.
Latest NOVT Form 4 filings
Most recent disclosures. Sign up to filter by score, transaction code, or insider role.
Other Technology tickers with recent insider activity
Top insiders trading NOVT
13F funds holding NOVT
Frequently asked
- How many insider trades does FilingIQ track for NOVT?
- FilingIQ tracks 715 Form 4 insider transactions for NOVT (NOVANTA INC), covering filings from May 17, 2016 onwards. 1 of those are dated within the last 90 days.
- Are NOVT insiders net buyers or net sellers?
- Across the full Form 4 history for NOVT, 0 transactions (0%) were open-market purchases and 274 (38%) were open-market sales. Compensatory awards and option exercises are filtered out of these counts.
- Where does NOVT insider data come from?
- Every transaction shown on this page is sourced directly from SEC EDGAR Form 4 filings. FilingIQ normalises insider identity across reporting variations and scores discretionary open-market purchases and sales on its multi-factor composite model.
- What sector is NOVT in?
- NOVANTA INC (NOVT) is classified in the Technology sector, specifically Scientific & Technical Instruments, with a current market capitalisation of $5.27B.
Methodology & sources
Every NOVT insider transaction shown on FilingIQ is parsed directly from a public SEC Form 4 XML filing. Insider identity is normalised across reporting variants (CIK changes, name spellings, related-party indirect holdings). The FilingIQ composite score is documented in full on the team page and algo disclosure. Not investment advice; see disclaimer.